News

Sartorius Stedim Biotech (SSB) and SAFC Biosciences have signed a global partnership agreement. It combines Sartorius Stedim Biotech’s expertise in filtration and liquid handling systems, with SAFC Biosciences’

Xoma has reported positive results from single dose and multiple dose subcutaneous arms of the randomized, placebo-controlled US phase 1 clinical trial of Xoma 052, in type 2

Inspiration Biopharmaceuticals has announced the positive preclinical safety, toxicology and preliminary pharmacokinetic data on IB1001. Its a novel recombinant Factor IX product intended to treat patients with hemophilia

I-many has announced that Graceway Pharmaceuticals is processing its complete government pricing reporting functions with I-many Government Pricing 6.5. Reportedly, using I-many’s Formula Builder technology and flexible Web

Sunquest has introduced a new offering for its laboratory and point-of-care solution suite. It is focused on patient safety, efficiency and cost-saving workflow improvements, while providing demonstrable benefits

NovImmune has selected Medidata’s Trial Planning product suite, to support the development of its pipeline of biologics for immune-related disorders. NovImmune has utilized Medidata Grants Manager and CRO

We will continue to evaluate our operations and organization to ensure they are in line with our commitment to develop high quality systems, stated Dr. Gioacchino De Chirico,

Medarex has intitiated phase 2 clinical trial of FG-3019 in patients with type 2 diabetes and advanced kidney disease. In this regard, Medarex will receive a milestone payment

In its order, the Court also set to August 13, 2009 the bar date for the filing of a proof of claim. Creditors who fail to file a